期刊文献+

启动子工程改造大肠杆菌K4生产果糖软骨素 被引量:2

Promoter engineering of Escherichia coli K4 for production of fructosylated chondroitin
下载PDF
导出
摘要 为了进一步提高大肠杆菌K4发酵生产果糖软骨素(K4CPS)的产量,将合成基因簇region 3启动子(PR3)3'端非翻译区(UTR)进行缺失突变,研究其对突变菌株K4CPS合成的影响。研究表明:在ops序列(RfaH蛋白结合位点)存在时,PR3启动子强度和K4CPS产量与UTR的长度变化无关;但ops序列缺失时,UTR的延长可导致PR3启动子的强度和K4CPS产量均低于对照菌株;反之,UTR的缩短能显著提高PR3启动子的强度,进而使K4CPS产量比原菌增加了46%,达到751 mg/L。 The capsular polysaccharide of Escherichia coli K4 was almost identical to chondroitin, a commercially valuable biopolymer.In order to further improve the productivity of K4CPS by E.coli K4, the modification of 3′ untranslated region(UTR) of the capsule gene cluster region 3 promoter(PR3) were investigated.The mutants with UTR deletion were screened and confirmed by PCR analysis and sequencing.The fermentation and quantitative real time RCR results suggested that the changes of UTR sequence as ops sequence remain did not affect the production of K4CPS and the transcription of PR3.Compared with the wild type,PR3 transcription level and the K4CPS yield of the insertion mutant with ops sequence deletion were decreased.Mutant strain was constructed by deleting both of UTR and ops sequence,however,PR3 transcription level was increased by 2-fold and the K4CPS yield reached 751 mg/L,with an increase of 46%.
出处 《生物加工过程》 CAS CSCD 2014年第3期19-25,共7页 Chinese Journal of Bioprocess Engineering
基金 中组部青年拔尖人才支持计划 国家重点基础研究发展计划(973计划)(2013CB733600) 江苏省科技支撑计划(2012617) 江苏省杰出青年基金(BK2012002)
关键词 硫酸软骨素 大肠杆菌K4 启动子工程 RED同源重组 chondroitin sulfate Escherishia coli promoter engineering Red recombination
  • 相关文献

参考文献29

  • 1翟中和,王喜忠,丁明孝.细胞生物学[M].3版.北京:高等教育出版社,2008:284-285.
  • 2Zhou S. Health food useful for improving water content of skin, obtained by mixing components including hyaluronic acid, chondroitin sulfate, fish collagen, vitamin C powder, glycine,proline,extract of grape seeds and starch : CN, 102210425A [ P ]. 2011-10-12.
  • 3Wada T, Mano T, Tanouchi M. Composition useful in pharmaceuticals and food-drlnks fbr treating asthenopia, comprises mixture of chondroitin sulfate: WO, 2011136159A1 [ P ]. 2011- 03-11.
  • 4Schiraldi C, Cimini D, DeRosa M. Production of chondroitin sulfate and chondroitin [ J ]. Appl Microbiol Biotechnol, 2010,87 (4) : 1209-1220.
  • 5Lauder R.Chondroitin sulphate:a complex molecule with potential impacts on a wide range of biological systems [ J ]. Complement Ther Med,2009,17(1) :56-62.
  • 6DeAngelis P. Chondroitin synthase gene and methods of making and using same : US,7569386B2[ P ] .2005-06-24.
  • 7吴秋林,刘立明,陈坚.发酵法生产硫酸软骨素的研究进展[J].生物工程学报,2012,28(11):1281-1293. 被引量:5
  • 8Rrodriguez M L, Jann B, Janu K. Structure and serological characteristics of the capsular K4 antigen of Escherichia coli 05 : K4:H4, a fi'uctose-containing p,,lysaccharide with a chondroitin backbone[ J] .Eur J Biochem, 1988,177( 1 ) : 117-124.
  • 9DeAngelis P L, Gunay N S, Toida T, et al. Identification of the capsular polysaccharides of type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively [ J ]. Carbohydr Res,2002,337(17) : 1547-1552.
  • 10Jolly J, Klimaszewski K, Nakanishi Y, et al. Microbial-derived chondroitin sulfate : US ,20100063001A1 [ P ] .2009-06-03.

二级参考文献48

  • 1翟中和,王喜忠,丁明孝.细胞生物学.3版.北京:高等教育出版社,2008:528—529.
  • 2Zhou S. Health food useful for improving water content of skin, obtained by mixing components including hyaluronic acid, chondroitin sulfate, fish collagen, vitamin C powder, glycine, proline, extract of grape seeds and starch: CN, 102210425A, 2011-10-12.
  • 3Wada T, Mano T, Tanouchi M. Composition useful in pharmaceuticals and food-drinks for treating asthenopia, comprises mixture of chondroitin sulfate: WO, 2011136159A1, 2011-03-11.
  • 4Schiraldi C, Cimini D, DeRosa M. Production of chondroitin sulfate and chondroitin. Appl Microbiol Biotechnol, 2010, 87(4): 1209-1220.
  • 5Lauder R. Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. Complement Ther Med, 2009, 17(1): 56-62.
  • 6Jolly JF, Klimaszewski K, Nakanishi Y, et al. Microbial-derived chondroitin sulfate: US, 20100063001A1, 2009-06-03.
  • 7Rrodriguez ML, Jann B, Jann K. Structure and serological characteristics of the capsular K4 antigen of Escherichia coli 05: K4: H4, a fructose-containing polysaccharide with a chondroitin backbone. Eur J Biochem, 1988, 177(1): 117-124.
  • 8Bedini E, DeCastro C, DeRosa M, et al. A microbiological-chemical strategy to produce chondroitin Sulfate A,C. Angew Chem Int Ed Engl, 2011, 50(27): 6160-6163.
  • 9DeAngelis PL, Gunay NS, Toida T, et al. Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively. Carbohydr Res, 2002, 337(17): 1547-1552.
  • 10Chong BF, Blank LM, Mclaughlin R, et alMicrobial hyaluronic acid production. Appl Mierobiol Biotechnol, 2005, 66(4): 341-351.

共引文献6

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部